These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11292123)

  • 21. New drugs for asthma.
    Barnes PJ
    Nat Rev Drug Discov; 2004 Oct; 3(10):831-44. PubMed ID: 15459674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the interleukin pathway in the treatment of asthma.
    Chung KF
    Lancet; 2015 Sep; 386(9998):1086-96. PubMed ID: 26383000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research on inflammatory mediators in asthma: new therapeutic approaches].
    Magnan A; Molimard M; Braunstein G; Devillier P
    Therapie; 1999; 54(4):447-61. PubMed ID: 10667111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the pathogenesis of allergic asthma using mouse models.
    Leong KP; Huston DP
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):96-109; quiz 110,. PubMed ID: 11527255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecularly targeted therapies for asthma: Current development, challenges and potential clinical translation.
    Sulaiman I; Lim JC; Soo HL; Stanslas J
    Pulm Pharmacol Ther; 2016 Oct; 40():52-68. PubMed ID: 27453494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulation as asthma therapy: where do we stand?
    Barnes PJ
    Eur Respir J Suppl; 1996 Aug; 22():154s-159s. PubMed ID: 8871062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies.
    Palomares Ó; Sánchez-Ramón S; Dávila I; Prieto L; Pérez de Llano L; Lleonart M; Domingo C; Nieto A
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferulic acid supresses Th2 immune response and prevents remodeling in ovalbumin-induced pulmonary allergy associated with inhibition of epithelial-derived cytokines.
    Sin Singer Brugiolo A; Carvalho Gouveia AC; de Souza Alves CC; de Castro E Silva FM; Esteves de Oliveira É; Ferreira AP
    Pulm Pharmacol Ther; 2017 Aug; 45():202-209. PubMed ID: 28689020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient stratification and the unmet need in asthma.
    Swedin L; Saarne T; Rehnberg M; Glader P; Niedzielska M; Johansson G; Hazon P; Catley MC
    Pharmacol Ther; 2017 Jan; 169():13-34. PubMed ID: 27373855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New concepts in the pathogenesis and treatment of allergic asthma.
    Grayson MH; Bochner BS
    Mt Sinai J Med; 1998 Sep; 65(4):246-56. PubMed ID: 9757744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacillus subtilis KCTC 11782BP-produced alginate oligosaccharide effectively suppresses asthma via T-helper cell type 2-related cytokines.
    Bang MA; Seo JH; Seo JW; Jo GH; Jung SK; Yu R; Park DH; Park SJ
    PLoS One; 2015; 10(2):e0117524. PubMed ID: 25658604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting T cells for asthma.
    Heijink IH; Van Oosterhout AJ
    Curr Opin Pharmacol; 2005 Jun; 5(3):227-31. PubMed ID: 15907907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells in allergic airway inflammation.
    Bharadwaj AS; Bewtra AK; Agrawal DK
    Can J Physiol Pharmacol; 2007 Jul; 85(7):686-99. PubMed ID: 17823633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protocatechuic acid suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model.
    Wei M; Chu X; Guan M; Yang X; Xie X; Liu F; Chen C; Deng X
    Int Immunopharmacol; 2013 Apr; 15(4):780-8. PubMed ID: 23357785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation.
    Nixon J; Newbold P; Mustelin T; Anderson GP; Kolbeck R
    Pharmacol Ther; 2017 Jan; 169():57-77. PubMed ID: 27773786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The future of asthma therapy].
    Solèr M
    Schweiz Med Wochenschr; 2000 Feb; 130(8):277-81. PubMed ID: 10726286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine and anti-cytokine therapy in asthma: ready for the clinic?
    Desai D; Brightling C
    Clin Exp Immunol; 2009 Oct; 158(1):10-9. PubMed ID: 19737225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging treatments for asthma.
    Blease K; Lewis A; Raymon HK
    Expert Opin Emerg Drugs; 2003 May; 8(1):71-81. PubMed ID: 14610913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redefining approaches to asthma: developing targeted biologic therapies.
    Arron JR; Scheerens H; Matthews JG
    Adv Pharmacol; 2013; 66():1-49. PubMed ID: 23433454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.